Page - (000327) - in Biomedical Chemistry: Current Trends and Developments

Compounds. European Journal of Organic Chemistry, (30), 5099-5111. Hallberg, M., & Nyberg, F. (2003). Neuropeptide conversion to bioactive fragments—an important pathway in neuromodulation. Current Protein & Peptide Science, 4(1), 31-44. Harrison, S., & Geppetti, P. (2001). Substance P. International Journal of Biochemistry and Cell Biology, 33(6), 555-576. Hasenohrl, R. U., Gerhardt, P., & Huston, J. P. (1991). Naloxone blocks conditioned place preference induced by substance P and [pGlu6]-SP(6-11). Regulatory peptides, 35(3), 177- 187. Heuillet, E., Menager, J., Fardin, V., et al. (1993). Characterization of a Human Nk1 Tachykinin Receptor in the Astrocytoma Cell-Line U-373 Mg. Journal of Neurochemistry, 60(3), 868-876. Houston, J. B. (1994). Utility of in-Vitro Drug-Metabolism Data in Predicting in-Vivo Metabolic- Clearance. Biochemical Pharmacology, 47(9), 1469-1479. Hruby, V. J. (1982). Conformational Restrictions of Biologically-Active Peptides Via Amino-Acid Side-Chain Groups. Life Sciences, 31(3), 189-199. Hruby, V. J. (2002). Designing peptide receptor agonists and antagonists. Nature Reviews: Drug Discovery, 1(11), 847-858. Hubatsch, I., Ragnarsson, E. G. E., & Artursson, P. (2007). Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols, 2(9), 2111-2119. Humphrey, M. J., & Ringrose, P. S. (1986). Peptides and Related Drugs - a Review of Their Absorption, Metabolism, and Excretion. Drug Metabolism Reviews, 17(3-4), 283-310. Huston, J. P., Hasenoehrl, R. U., Boix, F., et al. (1993). Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity. Psychopharmacology, 112(2-3), 147-162. Hutchinson, E. G., & Thornton, J. M. (1994). A Revised Set of Potentials for Beta-Turn Formation in Proteins. Protein Science, 3(12), 2207-2216. Igwe, O. J., Kim, D. C., Seybold, V. S., et al. (1990). Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes. Journal of Neuroscience, 10(11), 3653-3663. Kerns, E. H., & Di, L. (2008). Drug-like Properties: Concepts, Structure Design and Methods. London, UK: Elsevier Inc. Kim, H. O., & Kahn, M. (2000). A merger of rational drug design and combinatorial chemistry: Development and application of peptide secondary structure mimetics. Combinatorial Chemistry and High Throughput Screening, 3(3), 167-183. Kramer, M. S., Cutler, N., Feighner, J., et al. (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science, 281(5383), 1640-1645. Kreeger, J. S., & Larson, A. A. (1993). Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice. European Journal of Pharmacology, 238(1), 111-115. Kruszynski, R., Fichna, J., do-Rego, J.-C., et al. (2005). Synthesis and biological activity of N- methylated analogs of endomorphin-2. Bioorganic &Medicinal chemistry, 13(24), 6713-6717. Lewis, P. N., Momany, F. A., & Scheraga, H. A. (1973). Chain Reversals in Proteins. Biochimica Et Biophysica Acta, 303(2), 211-229. Matthews, B. W. (1972). Gamma-Turn - Evidence for a New Folded Conformation in Proteins.